Hiking Cigarette Prices Discourages Teens From Taking Up the Habit

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 7
Volume 10
Issue 7

WASHINGTON-A long-term University of Michigan study of smoking among 8th and 10th graders indicates that raising the price of cigarettes can prevent some youths from beginning to use tobacco products. The researchers examined three initiation points: any smoking at all (including experimentation), daily smoking, and smoking a half-pack or more a day. Depending on the type of initiation, an increase of 10% in the price of cigarettes decreased the probability that an adolescent would begin smoking by 3% to 10%.

WASHINGTON—A long-term University of Michigan study of smoking among 8th and 10th graders indicates that raising the price of cigarettes can prevent some youths from beginning to use tobacco products. The researchers examined three initiation points: any smoking at all (including experimentation), daily smoking, and smoking a half-pack or more a day. Depending on the type of initiation, an increase of 10% in the price of cigarettes decreased the probability that an adolescent would begin smoking by 3% to 10%.

Recent Videos
“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.
Data from the phase 3 DeLLphi-304 trial at ASCO 2025 revealed a survival advantage with tarlatamab vs chemotherapy in second-line ES-SCLC.
The new peritoneal surface malignancy care guidelines had clinicians gather from every disease state to show increased representation.
The FDA approval of tarlatamab in SCLC has received much press attention, according to Daniel R. Carrizosa, MD, MS.
These new guidelines aim to alleviate some of the problems caused by patients with peritoneal metastases being diagnosed with the disease in late stages.
A combined cohort composed of patients from the TROPION-Lung01 and TROPION-Lung-05 trials showed a survival advantage with dato-DXd vs docetaxel.
The National ICE-T Conference may inspire future collaboration between community and academic oncologists in the management of different cancers.
4 experts in this video
Related Content